Increased kidney metabolism as a pathway to kidney tissue hypoxia and damage: Effects of triiodothyronine and dinitrophenol in normoglycemic rats

Advances in Experimental Medicine and Biology

Volumn 789, Issue , 2013, Pages 9-14

  Friederich Persson, Malou ^a   Persson, Patrik ^a   Fasching, Angelica ^a   Hansell, Peter ^a   Nordquist, Lina ^a   Palm, Fredrik ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; GLUCOSE; LIOTHYRONINE; OXYGEN; SODIUM ION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; HYPERGLYCEMIA; HYPOXEMIA; KIDNEY BLOOD FLOW; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY METABOLISM; KIDNEY PARENCHYMA; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; PROTEINURIA; RAT; SODIUM EXCRETION; URINE FLOW RATE; WEIGHT REDUCTION;

ANIMALS; CELL HYPOXIA; DINITROPHENOLS; DRUG EFFECTS; KIDNEY CORTEX; KIDNEY DISEASES; MALE; METABOLISM; OXIDATIVE STRESS; OXYGEN; OXYGEN CONSUMPTION; PATHOLOGY; PHARMACOLOGY; PHYSIOLOGY; RATS; RATS, SPRAGUE-DAWLEY; TRIIODOTHYRONINE;

RATTUS;

EID: 84934443703     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-7411-1_2     Document Type: Conference Paper

References (16)

1. Nangaku M (2006) Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 17(1):17-25
2. Mimura I, Nangaku M (2010) The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease. Nat Rev Nephrol 6(11):667-678
3. Parascandola J (1974) Dinitrophenol and bioenergetics: an historical perspective. Mol Cell Biochem 5(1-2):69-77
4. Echtay KS, Roussel D, St-Pierre J, Jekabsons MB, Cadenas S, Stuart JA et al (2002) Superoxide activates mitochondrial uncoupling proteins. Nature 415(6867):96-99
5. Wrutniak-Cabello C, Casas F, Cabello G (2001) Thyroid hormone action in mitochondria. J Mol Endocrinol 26(1):67-77
6. Beinhauer L (1934) Urticaria following the use of dinitrophenol. WV Med J 7:466-477
7. Imerman S, Imerman C (1936) Dinitrophenol poisoning with thrombocytopenia, granulope-nia, anemia and purpura complicated by lung abscess. JAMA 106:1085-1088
8. Weetman AP, Tomlinson K, Amos N, Lazarus JH, Hall R, McGregor AM (1985) Proteinuria in autoimmune thyroid disease. Acta Endocrinol (Copenh) 109(3):341-347
9. Perez-Abud R, Rodriguez-Gomez I, Villarejo AB, Moreno JM, Wangensteen R, Tassi M, et al. Salt sensitivity in experimental thyroid disorders in rats. Am J Physiol Endocrinol Metab 301(2):E281-E287
10. 2 in the face of altered perfusion: a phenomenon specific to the renal cortex and independent of resting renal oxygen consumption. Clin Exp Pharmacol Physiol 38(4):247-254
11. Fine LG, Orphanides C, Norman JT (1998) Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int Suppl 65:S74-S78
12. Nangaku M (2004) Hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. Nephron Exp Nephrol 98(1):e8-e12
13. Singh DK, Winocour P, Farrington K (2008) Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy. Nat Clin Pract Nephrol 4(4):216-226
14. Palm F, Nordquist L. Renal tubulointerstitial hypoxia: cause and consequence of kidney dysfunction. Clin Exp Pharmacol Physiol 38(7):424-430
15. Hochman ME, Watt JP, Reid R, O'Brien KL (2007) The prevalence and incidence of end-stage renal disease in Native American adults on the Navajo reservation. Kidney Int 71(9):931-937
16. Sayarlioglu H, Erkoc R, Dogan E, Topal C, Algun E, Erem C et al (2005) Nephropathy and retinopathy in type 2 diabetic patients living at moderately high altitude and sea level. Ren Fail 27(1):67-71